APLT - Applied Therapeutics net loss widens in Q1 June, 21 2019 09:38 AM Applied Therapeutics Inc. Applied Therapeutics (APLT) Q1 results: Revenues: $0; R&D Expense: $6.9M; SG&A: $1.9M; Net Loss: ($8.7M); Loss Per Share: ($1.58); Quick Assets: $14.7M (-21.4%).More news on: Applied Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...